Sector Chart Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
1.430 ^USD	-0.69%		-13.33%	-4.03%

11-13	Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-03	Marker Therapeutics, Inc. Announces Data from Phase 1 APOLLO Study to Present in Two Posters at 67Th American Society of Hematology Annual Meeting and Exposition	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E
MARKER THERAPEUTICS, INC.	24.01M			-	-	-
LONZA GROUP AG	45.48B
BEONE MEDICINES AG	38.33B
CELLTRION, INC.	36.26B
IQVIA HOLDINGS INC.	28.64B
REVOLUTION MEDICINES, INC.	18.82B	-	-	-	-	-